Curi RMB Capital LLC Sells 2,459 Shares of Kadant Inc $KAI

Key Points

• Curi RMB Capital LLC has decreased its stake in Kadant Inc by 3.2%, selling 2,459 shares to hold approximately 73,635 shares worth $24.8 million.
• Several institutional investors have increased their holdings in Kadant, with the largest being Vanguard Group Inc., which raised its stake by 9.4%, bringing its total to over 1.3 million shares valued at nearly $449 million.
• Kadant's recent earnings report revealed an EPS of $2.31, surpassing analysts' expectations, although the company's revenue declined 7.3% year-over-year.

Curi RMB Capital LLC lowered its stake in shares of Kadant Inc (NYSE:KAI - Free Report) by 3.2% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 73,635 shares of the industrial products company's stock after selling 2,459 shares during the quarter. Curi RMB Capital LLC owned about 0.63% of Kadant worth $24,808,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in KAI. Opal Wealth Advisors LLC bought a new stake in shares of Kadant during the 1st quarter worth $30,000. Optimum Investment Advisors lifted its position in Kadant by 50.0% during the 1st quarter. Optimum Investment Advisors now owns 150 shares of the industrial products company's stock worth $51,000 after acquiring an additional 50 shares during the last quarter. SVB Wealth LLC bought a new stake in Kadant during the first quarter valued at about $54,000. GAMMA Investing LLC grew its position in shares of Kadant by 348.1% in the first quarter. GAMMA Investing LLC now owns 242 shares of the industrial products company's stock valued at $82,000 after purchasing an additional 188 shares during the last quarter. Finally, Russell Investments Group Ltd. increased its stake in shares of Kadant by 982.6% in the first quarter. Russell Investments Group Ltd. now owns 249 shares of the industrial products company's stock worth $84,000 after purchasing an additional 226 shares during the period. Institutional investors and hedge funds own 96.13% of the company's stock.

Insiders Place Their Bets

In other news, Director Thomas C. Leonard sold 415 shares of the company's stock in a transaction that occurred on Wednesday, August 27th. The stock was sold at an average price of $338.41, for a total value of $140,440.15. Following the sale, the director directly owned 4,250 shares in the company, valued at approximately $1,438,242.50. This represents a 8.90% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 1.20% of the company's stock.

Analyst Upgrades and Downgrades

KAI has been the subject of several recent analyst reports. Wall Street Zen upgraded Kadant from a "sell" rating to a "hold" rating in a research note on Saturday, July 5th. DA Davidson raised their price objective on shares of Kadant from $275.00 to $300.00 and gave the stock a "neutral" rating in a research note on Monday, August 4th. Finally, Barrington Research reiterated an "outperform" rating and set a $380.00 target price on shares of Kadant in a research note on Tuesday, July 29th. One analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $340.00.

Kadant Stock Performance

Shares of NYSE KAI traded down $9.35 during trading hours on Tuesday, reaching $316.34. The stock had a trading volume of 35,970 shares, compared to its average volume of 140,150. The company has a market cap of $3.73 billion, a price-to-earnings ratio of 35.23 and a beta of 1.25. Kadant Inc has a twelve month low of $281.30 and a twelve month high of $429.95. The business's fifty day moving average is $332.13 and its two-hundred day moving average is $327.63. The company has a debt-to-equity ratio of 0.26, a current ratio of 2.38 and a quick ratio of 1.53.

Kadant (NYSE:KAI - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The industrial products company reported $2.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.94 by $0.37. Kadant had a net margin of 10.34% and a return on equity of 12.62%. The firm had revenue of $255.27 million for the quarter, compared to analyst estimates of $245.99 million. During the same quarter in the previous year, the firm posted $2.81 EPS. The business's revenue for the quarter was down 7.3% on a year-over-year basis. Kadant has set its Q3 2025 guidance at 2.130-2.230 EPS. FY 2025 guidance at 9.050-9.250 EPS. As a group, research analysts expect that Kadant Inc will post 9.97 EPS for the current year.

Kadant announced that its Board of Directors has authorized a share repurchase plan on Thursday, May 15th that authorizes the company to repurchase $50.00 million in outstanding shares. This repurchase authorization authorizes the industrial products company to repurchase up to 1.3% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company's board of directors believes its stock is undervalued.

Kadant Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Thursday, October 9th will be issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend is Thursday, October 9th. Kadant's payout ratio is presently 15.14%.

About Kadant

Kadant Inc supplies technologies and engineered systems worldwide. It operates in three segments: Flow Control, Industrial Processing, and Material Handling. The Flow Control segment develops, manufactures, and markets fluid-handling systems and equipment, such as rotary joints, syphons, turbulator bars, expansion joints, and engineered steam and condensate systems; and doctoring, cleaning, and filtration systems and related consumables consisting of doctor systems and holders, doctor blades, cleaning shower and fabric-conditioning systems, forming systems and wear surfaces, and water-filtration systems.